Linden Thomas Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.6M Buy
6,333
+206
+3% +$210K 0.61% 23
2026
Q1
$5.64M Buy
6,127
+1,017
+20% +$1.03M 0.54% 24
2025
Q4
$5.49M Buy
5,110
+142
+3% +$136K 0.56% 31
2025
Q3
$3.79M Buy
4,968
+43
+0.9% +$32K 0.38% 63
2025
Q2
$3.84M Sell
4,925
-2,849
-37% -$2.21M 0.42% 63
2025
Q1
$6.42M Buy
7,774
+297
+4% +$247K 0.83% 8
2024
Q4
$5.77M Buy
7,477
+335
+5% +$277K 0.73% 11
2024
Q3
$6.33M Buy
7,142
+334
+5% +$300K 0.86% 6
2024
Q2
$6.16M Sell
6,808
-1,353
-17% -$1.08M 0.95% 5
2024
Q1
$6.35M Sell
8,161
-472
-5% -$336K 1.02% 5
2023
Q4
$5.03M Buy
8,633
+518
+6% +$302K 0.94% 5
2023
Q3
$4.36M Sell
8,115
-45
-0.6% -$23.2K 0.97% 2
2023
Q2
$3.83M Buy
8,160
+464
+6% +$195K 0.85% 9
2023
Q1
$2.64M Buy
7,696
+557
+8% +$188K 0.66% 19
2022
Q4
$2.61M Buy
+7,139
New +$2.53M 0.74% 13

Other funds holding LLY

Linden Thomas Advisory Services's LLY Position: Q2 2026 in Review

Linden Thomas Advisory Services increased its Eli Lilly (LLY) stake by 3.4% in Q2 2026, buying an estimated $210K and bringing the position to 6,333 shares worth $7.6M. The position accounts for 0.61% of the portfolio, ranked #23.

Linden Thomas Advisory Services first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Linden Thomas Advisory Services held 6,333 shares of Eli Lilly worth $7.6M as of Q2 2026.
  • Linden Thomas Advisory Services bought 206 Eli Lilly shares in Q2 2026, an estimated $210K.
  • Eli Lilly made up 0.61% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #23 holding.
  • Linden Thomas Advisory Services first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.